Silo Pharma (NASDAQ: SILO) today announced favorable preclinical results for SP-26, its novel extended-release ketamine implant aimed at treating fib ...

New research confirms that gut microbes from fibromyalgia patients trigger chronic pain, immune activation, and nerve changes ...

Successfully demonstrates strong tolerability, sustained drug release and safety SARASOTA, FL, April 30, 2025 (GLOBE NEWSWIRE ...

Silo Pharma, Inc. (NASDAQ:SILO) on Wednesday released results for its preclinical study evaluating SP-26. SP-26 is a ketamine ...

Medical cannabis has gained significant attention in recent years as a potential treatment for various health conditions, particularly chronic pain. As more research emerges, it’s becoming clearer ...

Fibromyalgia can be a debilitating illness due to its persistent fatigue and muscle aches. It can seriously and negatively ...

People could benefit from asking their doctor to test them for this condition, which is often 'unaffected by standard ...

Overall, CBT-I may be more effective than pharmacological therapies for improving sleep quality among patients with fibromyalgia.

McGill University-led research has discovered that transplanting gut microbiota from women with fibromyalgia into mice ...

People with osteoarthritis are more likely to have other pain-related and psychological conditions including depression, CFS, ...

Recent research indicates that the use of psychedelics has the potential to significantly reduce the experience of chronic ...

Research suggests that better understanding the psychological and neurological components of chronic pain may lead to better ...